The U.S. Food and Drug Administration is planning on unveiling a new rule where they will implement new health warnings in regard to cigarette packages.
Some in Congress are hoping the Republican sponsored Fair Care Act of 2019 will open the floodgates for Americans to buy health insurance.
Two Republican senators recently introduced a bill they claim would combat U.S. drug shortages and drive down the prices of drugs and medical devices by allowing patients to select treatments approved in other countries.
The U.S. Food and Drug Administration is using some new tools in its drug approval process and at least one prominent industry leader is giving the government entity a thumb’s up.
The American Vaping Association says FDA fear-mongering on vaping products for minors could end up making the products more enticing.
The Food and Drug Administration unveiled yet another draft guidance on opioid addiction, but one doctor remains unimpressed.
The Food and Drug Administration recently unveiled a new draft guidance for tackling opioid addiction, and scheduled a public hearing for Sept. 17 to discuss the crisis.
The Food and Drug Administration has been gathering comments on how to regulate cannabis products, but a cannabis industry expert says FDA should lay off and let states do their jobs.
A Hawaii doctor opined in a column if the Food and Drug Administration should share in pharmaceutical and medical research profit.
Some believe with the advent of gene therapy, the future of medicine has been seen.
North Carolina House Bill 934, which passed unanimously 114-0, was sent to the State Senate where it currently is in committee.
When the FDA made the announcement, it said it would open past records within weeks. So why did the FDA have such a policy and why was it secret?
How much is too much when it comes to the price of prescription drugs? This week, U.S. Senators John Cornyn (R-Texas) and Richard Blumenthal (D-Connecticut) crossed party lines and introduced a bill to answer that very question.
North Carolina passed a Right to Try law back in 2015 yet a bill introduced in April could expand that stem cell treatment law.
WASHINGTON -- The New York Times recently published a lengthy story about stem cell treatments, describing the Food and Drug Administration’s approach as industry friendly.
Seven former Food and Drug Administration commissioners suggested in a couple of articles that the FDA should become an independent agency
Two papers written by seven former FDA commissioners suggest the organization should become an independent agency.
Citizensʼ Council for Health Freedom Media president Twila Brase says the current FDA drug approval process is too long and expensive.
David Gortler, a professor of pharmacology and a former FDA official, says the FDA needs to do more to ensure the quality of drugs delivered to the U.S. market, with particular concern given to generic drugs produced in “sweatshop” countries.